172 related articles for article (PubMed ID: 32788620)
1. Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data.
Bonaldo G; Noseda R; Ceschi A; Vaccheri A; Motola D
Sci Rep; 2020 Aug; 10(1):13601. PubMed ID: 32788620
[TBL] [Abstract][Full Text] [Related]
2. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
Haber P; Tate J; Marquez PL; Moro PL; Parashar U
Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969
[TBL] [Abstract][Full Text] [Related]
3. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
5. RotaTeq vaccine adverse events and policy considerations.
Geier DA; King PG; Sykes LK; Geier MR
Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.
Bonaldo G; Vaccheri A; D'Annibali O; Motola D
Br J Clin Pharmacol; 2019 Mar; 85(3):634-643. PubMed ID: 30569481
[TBL] [Abstract][Full Text] [Related]
7. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
Haber P; Parashar UD; Haber M; DeStefano F
Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687
[TBL] [Abstract][Full Text] [Related]
8. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
9. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
[TBL] [Abstract][Full Text] [Related]
10. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.
Verstraeten T; Baughman AL; Cadwell B; Zanardi L; Haber P; Chen RT;
Am J Epidemiol; 2001 Dec; 154(11):1006-12. PubMed ID: 11724716
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
Felicetti P; Trotta F; Bonetto C; Santuccio C; Brauchli Pernus Y; Burgner D; Chandler R; Girolomoni G; Hadden RD; Kochhar S; Kucuku M; Monaco G; Ozen S; Pahud B; Phuong L; Bachtiar NS; Teeba A; Top K; Varricchio F; Wise RP; Zanoni G; Živkovic S; Bonhoeffer J;
Vaccine; 2016 Dec; 34(51):6634-6640. PubMed ID: 26392009
[TBL] [Abstract][Full Text] [Related]
12. Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.
Lepage P; Vergison A
Expert Opin Biol Ther; 2007 Dec; 7(12):1881-92. PubMed ID: 18034653
[TBL] [Abstract][Full Text] [Related]
13. Importance of on-time RotaTeq vaccination and long-term active surveillance.
Anderson EJ
Pediatrics; 2008 Nov; 122(5):1153-4; author reply 1154. PubMed ID: 18977997
[No Abstract] [Full Text] [Related]
14. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
Geier DA; King PG; Sykes LK; Geier MR
Med Sci Monit; 2012 Feb; 18(2):PH12-17. PubMed ID: 22293889
[TBL] [Abstract][Full Text] [Related]
15. [Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].
Pérez-Vilar S; Díez-Domingo J; Gomar-Fayos J; Pastor-Villalba E; Sastre-Cantón M; Puig-Barberà J
An Pediatr (Barc); 2014 Aug; 81(2):77-85. PubMed ID: 24252603
[TBL] [Abstract][Full Text] [Related]
16. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS).
Bakare N; Menschik D; Tiernan R; Hua W; Martin D
Vaccine; 2010 Sep; 28(40):6609-12. PubMed ID: 20674876
[TBL] [Abstract][Full Text] [Related]
17. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.
Niu MT; Erwin DE; Braun MM
Vaccine; 2001 Sep; 19(32):4627-34. PubMed ID: 11535310
[TBL] [Abstract][Full Text] [Related]
18. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
[TBL] [Abstract][Full Text] [Related]
19. [Immunization with monovalent oral vaccine against rotavirus in Mexico. Evaluation of the data of two years of the system of temporarily adverse event reports associated to vaccination (ETAV)].
Reyna-Figueroa J; Vidal-Vázquez RP; López-Collada VL
Rev Invest Clin; 2011; 63(4):391-8. PubMed ID: 22364039
[TBL] [Abstract][Full Text] [Related]
20. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
